Smiths Group PLC · LSE:SMIN

Smiths — FY2012 Earnings Presentation

53 slides from Smiths's earnings presentation, Sep 19, 2012

  1. Slide 1: Annual Results 19 September 2012

    Annual Results 19 September 2012 Bringing technology to life investor.relations@smiths.com www.smiths.com

  2. Slide 2: Forward-looking statements

    This document contains certain statements that are forward-looking statements. They appear in a number of places throughout this document and include statements regarding our intentions, beliefs or current expectations and those of our officers, directors and employees concerning, amongst other thin

  3. Slide 3: Introduction

    Introduction Philip Bowman Chief Executive GUARDION, Smiths Detection’s dual-technology chemical identifier Smiths Group plc Annual Results 2012 | 3

  4. Slide 4: Results highlights

    Results highlights Reported headline revenue up 7%; underlying up 5% Headline operating profit up 7%, underlying up 7% Headline EPS up 7% to 92.6p Cash conversion strong at 99% - free cash flow of £217m Return on capital employed up 10 basis points to 16.5% Dividend up 5% to 38.0 pence Smiths Group

  5. Slide 5: Delivering against our operational priorities

    Delivering against our operational priorities Launch new products from the divisional pipelines to drive top-line growth Company-funded new product investment up 9% - Strong pipeline of new product launches Increased investment in emerging markets to deliver faster sales growth Emerging market sales

  6. Slide 6: Promoting responsibility: An increased focus is delivering improvements

    Promoting responsibility: An increased focus is delivering improvements Recordable & lost time incident rates continue to improve Solid progress on environmental targets*** Lost time incident rate 1.03 • Energy: Recordable incident rate * 16% reduction • Greenhouse gases: 0.71 0.66 19% reduction Inc

  7. Slide 7: Financial review

    Financial review Peter Turner Finance Director John Crane supplies seals, filtration systems and bearings for oil and gas applications in Brazil Smiths Group plc Annual Results 2012 | 7

  8. Slide 8: Annual results 2012

    Annual results 2012 £m Headline* Statutory 2012 2011 2012 2011 reported underlying** Revenue 3,038 2,842 7% 5% 3,030 2,842 Operating profit 554 517 7% 7% 407 438 Margin 18.2% 18.2% - - 13.4% 15.4% Pre-tax profit 497 463 7% 7% 366 398 Basic EPS (p) 92.6 86.5 7% 65.4 77.8 Free cash flow 217 236 Divide

  9. Slide 9: Underlying headline sales and profit performance

    Underlying headline sales and profit performance Revenue growth Revenue Operating profit H1 H2 growth growth John Crane +13% +5% +9% +11% Smiths Medical -1% +6% +2% +2% Smiths Detection -11% +17% +3% +13% Smiths Interconnect -6% +12% +3% -9% Flex-Tek +2% +7% +5% +36% Group +1% +8% +5% +7% Smiths Gro

  10. Slide 10: Headline profit progression 2011 to 2012

    Headline profit progression 2011 to 2012 • Volume: Volume growth across all divisions • Price: Positive in John Crane and Flex-Tek offsetting negative pricing pressure elsewhere • Mix: Adverse mix in Interconnect and Detection • Increased R&D: Higher new product investment across nearly all division

  11. Slide 11: Group cash conversion

    Group cash conversion £m (for continuing activities) 2012 2011 Headline operating profit 554 517 Changes in working capital (23) (47) Share based payment 14 14 Capital expenditure (Property, plant & equipment) (46) (46) Depreciation 59 64 Development costs & other intangibles (net of amortisation an

  12. Slide 12: Improved return on capital from Flex-Tek, John Crane, Medical and Detection

    Improved return on capital from Flex-Tek, John Crane, Medical and Detection 12 months to 31 Jul 2012 12 months to 31 Jul 2011 30.0 28.4% 25.0 24.0% 21.9% 21.8% 20.0 17.6% 16.4% 16.5% 16.9% 15.7% % 15.0 12.3% 9.8% 10.3% 10.0 5.0 0.0 Smiths Group Flex-Tek John Crane Smiths Medical Smiths Smiths Detect

  13. Slide 13: Reconciliation: Headline operating profit to statutory profit

    Reconciliation: Headline operating profit to statutory profit £m Headline operating profit 554 Restructuring programmes (15) Litigation provision: John Crane, Inc. (40) Litigation provision: Titeflex Corporation (55) Revision of estimated rebates in Smiths Medical (8) Net acquisition and disposal ex

  14. Slide 14: Exceptional items: Restructuring programme delivering benefits

    Exceptional items: Restructuring programme delivering benefits Group-wide restructuring FY08-12 – now largely complete Costs to date Total planned costs Total planned savings £55m £56m £70m £m 2012 costs 2012 savings Savings to date Group-wide 3 14 70 Detection performance improvement FY12-14 Costs

  15. Slide 15: Smiths Detection: Performance improvement programme

    Smiths Detection: Performance improvement programme – achievements to date • Reducing costs – achieved net global headcount reduction of c. 200 or 8% • Sales and admin site at Morristown, NJ closed • Aligning X-ray manufacturing footprint to customer needs – focusing on 3 hubs: - Americas, Europe an

  16. Slide 16: Pensions: Deficit increased to £620m

    Pensions: Deficit increased to £620m, driven by lower discount rates Deficit movement since 31 July 2011 Cash contributions £m 2012 2013 Deficit at 31 July 2011 (199) Funded scheme Foreign exchange (4) contributions £115m £90m Return on assets 104 - Smiths Industries PS £36m £36m Contributions (net

  17. Slide 17: Strong balance sheet supports investment in acquisitions and growth

    Strong balance sheet supports investment in acquisitions and growth Interest split Currency split Debt split Net debt £m Borrowings 997 USD Cash (206) Fixed Euro Bank Floating other Public Net debt 791 £m Weighted average life of debt is 3.9 years 250 Credit Rating: 200 BBB+ (stable)/Baa2 (stable) 1

  18. Slide 18: Operational review and priorities

    Operational review and priorities Philip Bowman Chief Executive Smiths Interconnect supplies filters to improve network capacity for wireless telecommunications Smiths Group plc Annual Results 2012 | 18

  19. Slide 19: Delivering shareholder value – key themes

    Delivering shareholder value – key themes Investment strategies to accelerate growth are beginning to deliver Further opportunities for operational efficiencies – scale varies by division Improving performance and capabilities through cross-divisional working Sustain strong cash generation to fund g

  20. Slide 20: John Crane: Delivering sales growth, improving margins and returns

    John Crane: Delivering sales growth, improving margins and returns Underlying revenue Underlying headline profit Headline operating margin 2012 Revenue % (£973m) +50 bps 9% 11% 1 First-fit OEM 37% + + 21.6% Aftermarket 63% 2 Oil, gas & petrochem 39% 3 Chemical and pharma 8% 4 Distributors 7% Strong

  21. Slide 21: John Crane: Investing in future growth

    John Crane: Investing in future growth: new products and markets Increasing investment in new product development • 8% increase in new product development • Already investing in new engineering and test facilities • Plans to grow R&D investment by about 15% pa over next few years Expanding the servi

  22. Slide 22: John Crane: Outlook

    John Crane: Outlook Outlook • Strong order book provides visibility for first half growth • Margins will benefit from efficiency initiatives • Reinvest savings in growth opportunities: new products and markets John Crane seals are used in concentrated solar power plants Smiths Group plc Annual Resul

  23. Slide 23: Medical: Delivering sales growth from new products and markets

    Smiths Medical: Delivering sales growth from new products and markets Underlying revenue Underlying headline profit Headline operating margin 2012 Revenue* % (£864m) +10 bps 1 Medication delivery 28% + 2% + 2% 23.5% 2 Vital care 41% 3 Safety devices 31% Sales growth despite tough operating environme

  24. Slide 24: Medical: Investing in growth opportunities

    Smiths Medical: Investing in growth opportunities Committed to accelerating new product launches: investment up 9% to £34m or 3.9% of sales (2011: 3.7%) • Medfusion 4000 infusion pump – Launched in US and Canada • CADD-Solis VIP and PIB ambulatory pump – Released outside US • ViaValve™ Safety IV Cat

  25. Slide 25: Medical: Outlook

    Smiths Medical: Outlook Outlook • Developed markets are likely to remain challenging • US medical device tax scheduled for January 2013 • Focus will remain on investment in new product development • Investing in sales and marketing; increasing emerging market exposure • Cost savings benefits will be

  26. Slide 26: Detection: Improving sales trend; margins benefit from restructuring

    Smiths Detection: Improving sales trend; margins benefit from restructuring Underlying revenue Underlying headline profit Headline operating margin 2012 Revenue % (£519m) +50 bps 1 Transportation 47% + 3% + 13% 2 Ports & borders 16% 13.3% 3 Military 11% 4 Emergency responders 4% 5 Critical infrastru

  27. Slide 27: Detection: Investing in future growth through new products and markets

    Smiths Detection: Investing in future growth through new products and markets Increased investment in new products – strong pipeline of new launches • Company funded spend up 7% to £38m or 7.2% of sales • Total spend of £43m or 8.3% of sales Recent product launches • HI-SCAN 10080 XCT: next generati

  28. Slide 28: Detection: Outlook

    Smiths Detection: Outlook Outlook • Improved order book expected to support sales growth in FY13 • However, constraints to government budgets may affect sales growth • Margins will benefit from cost savings and operational efficiencies HI-SCAN 10080 XCT, the new baggage scanner has EU approval Smith

  29. Slide 29: Interconnect: Challenging trading environment affected margins

    Smiths Interconnect: Challenging trading environment affected margins Underlying revenue Underlying headline profit Headline operating margin 2012 Revenue % (£448m) -310 bps 1 Connectors 35% + 3% - 9% 14.7% 2 Microwave 45% 3 Power management 20% 3 Underlying sales helped by strong second half for Mi

  30. Slide 30: Interconnect: Investing in new products and emerging markets

    Smiths Interconnect: Investing in new products and emerging markets Continued investment in new product development • Company-funded R&D up 9% to £23m or 5.1% of sales (2011: 5.5%) • Total R&D spend of £27m or 6.0% of sales (2011: 6.6%) • More than 30% of sales come from products developed in last 3

  31. Slide 31: Interconnect: Outlook

    Smiths Interconnect: Outlook Outlook • Defence market is likely to remain challenging • Wireless network investment is essentially flat; tough comparator period • Semiconductors and data centres should improve but will depend on economic conditions • Margins will benefit from restructuring savings P

  32. Slide 32: Flex-Tek: Margins benefit from operational leverage

    Flex-Tek: Margins benefit from operational leverage Underlying revenue Underlying headline profit Headline operating margin 2012 Revenue % (£233m) +380 bps 1 Fluid Management 35% + 5% + 36% 16.3% 2 Construction 26% 3 Heat Solutions 24% 4 Flexible Solutions 15% Margins up 380 bps from higher volumes

  33. Slide 33: Flex-Tek: Outlook

    Flex-Tek: Outlook Outlook • Order book for aerospace customers remains positive • Residential construction market should continue to improve • Margins are strongly geared to increased volumes Flex-Tek’s lightweight, high pressure hoses improve airline fuel efficiency Smiths Group plc Annual Results

  34. Slide 34: Solid progress on our financial metrics despite tough trading conditions

    Solid progress on our financial metrics despite tough trading conditions Performance 2009-2012 Headline revenue growth CAGR +4.5% Headline operating margin +250 bps 18.2% Operating cash conversion Average 103% Return on capital +250 bps 16.5% Smiths Group plc Annual Results 2012 | 34

  35. Slide 35: Operational priorities for 2013

    Operational priorities for 2013 Deliver new product launches to accelerate sales growth Invest in sales and marketing capabilities in high growth markets Drive operational efficiencies to improve margins and support investment Sustain strong cash conversion to fund growth initiatives and enhance val

  36. Slide 36: John Crane

    John Crane A world-leading provider of products and Revenue £m 973 894 services for the major process industries, 790 786 including oil and gas, power generation, 626 chemical, pharmaceutical, pulp and paper, and mining sectors. 2008 2009 2010 2011 2012 Contribution to 2012 Revenue by sector 2012 Gr

  37. Slide 37: John Crane

    John Crane Delivering engineered solutions that keep process plants running, John Crane enhances customer productivity by providing advanced technology industrial products and performance-enhancing services backed by an exceptional global network. Customers: John Crane serves oil and gas and Competi

  38. Slide 38: John Crane: Volumes and price drive margin

    John Crane: Volumes and price drive margin; investing in sales growth £m 2012 2011 reported underlying Revenue 973 894 +9% +9% Headline operating profit 210 189 +11% +11% Margin 21.6% 21.1% +50 bps ROCE 24.0% 21.8% +220 bps Headline operating profit £m • Volume: Driven by both aftermarket and OEM, 2

  39. Slide 39: Smiths Medical

    Smiths Medical A leading supplier of specialist medical devices Headline revenue £m and equipment for global markets. 834 858 838 864 703 Our products are focused on the medication delivery, vital care and safety devices market segments. 2008 2009 2010 2011 2012 Contribution to 2012 Headline revenue

  40. Slide 40: Smiths Medical

    Smiths Medical In medication delivery, our devices help treat cancer patients and provide relief to those in pain. Our vital care products reduce hospital-acquired infections, manage patients’ airways before, during, and after surgery, maintain body temperature and assist reproduction through IVF th

  41. Slide 41: Medical: Investment is driving growth; funded by efficiency gains

    Smiths Medical: Investment is driving growth; funded by efficiency gains £m 2012 2011 reported underlying Headline revenue 864 838 +3% +2% Headline operating profit 203 196 +3% +2% Operating margin 23.5% 23.4% +10 bps ROCE 17.6% 16.9% +70 bps Headline operating profit £m • Volume: New product launch

  42. Slide 42: Smiths Detection

    Smiths Detection A world-leading designer and manufacturer Revenue £m 574 of sensors that detect and identify 509 501 510 519 explosives, narcotics, weapons, chemical agents, biohazards, nuclear & radioactive material and contraband. 2008 2009 2010 2011 2012 Contribution to 2012 Revenue by sector 20

  43. Slide 43: Smiths Detection

    Smiths Detection Our technology helps customers in the global transportation, ports and borders, critical infrastructure, military and emergency responder markets. We have the most comprehensive range of detection technologies in the world, including X-ray, trace detection, infra-red and gamma ray s

  44. Slide 44: Detection: Margins benefiting from operational efficiencies

    Smiths Detection: Margins benefiting from operational efficiencies £m 2012 2011 reported underlying Revenue 519 510 +2% +3% Headline operating profit 69 66 +6% +13% Margin 13.3% 12.8% +50 bps ROCE 10.3% 9.8% +50 bps Headline operating profit £m • Volume: Transportation, critical infrastructure, 2010

  45. Slide 45: Smiths Interconnect

    Smiths Interconnect Revenue £m A leader in electronic components and 449 sub-systems that connect, protect and control 379 critical systems for wireless telecommunications, 318 340 aerospace, defence, space, test, medical, rail 261 and industrial markets. 2008 2009 2010 2011 2012 Contribution to 201

  46. Slide 46: Smiths Interconnect

    Smiths Interconnect We design and manufacture products that connect, protect and control critical systems for the global data centre, wireless telecommunications, aerospace, defence, space, medical, rail, test and industrial markets. Our products are application-specific and incorporate innovative t

  47. Slide 47: Interconnect: Margins affected by challenging trading environment

    Smiths Interconnect: Margins affected by challenging trading environment £m 2012 2011 reported underlying Revenue 449 379 +18% +3% Headline operating profit 66 68 (2)% (9)% Margin 14.7% 17.8% (310) bps ROCE 12.3% 15.7% (340) bps Headline operating profit £m • Volume: Positive volume offset by advers

  48. Slide 48: Flex-Tek

    Flex-Tek A global provider of engineered components Revenue £m 233 that heat and move fluids and gases for the 206 222 212 221 aerospace, medical, industrial, construction and domestic appliance markets. 2008 2009 2010 2011 2012 Contribution to 2012 Revenue by sector 2012 Group revenue: 8% £233m 4 1

  49. Slide 49: Flex-Tek

    Flex-Tek Our flexible hosing and rigid tubing provide fluid management for fuel and hydraulic applications on commercial and military aircraft, deliver fuel gas and conditioned air in residential and commercial buildings, and provide respiratory care for medical applications. Flex-Tek heating elemen

  50. Slide 50: Flex-Tek: Volumes and pricing offset inflation pressures

    Flex-Tek: Volumes and pricing offset inflation pressures to grow margins £m 2012 2011 reported underlying Revenue 233 221 +6% +5% Headline operating profit 38 28 +38% +36% Margin 16.3% 12.5% +380 bps ROCE 28.4% 21.9% +650 bps Headline operating profit £m • Volume: Gains in aerospace and construction

  51. Slide 51: Net debt increased by £62m driven by acquisitions and dividends

    Net debt increased by £62m driven by acquisitions and dividends £m 2012 Net debt at start of period (729) Operating cash (after capex etc.) 549 Interest and tax (158) Exceptionals/Pensions (174) Free cash flow 217 Dividends (144) Acquisitions/disposals (120) Financing including net investment hedges

  52. Slide 52: Asbestos litigation

    Asbestos litigation Key facts Key figures • Production ceased in 1985 Gross provision £226m • Exposure within John Crane, Inc. Discounted pre-tax provision £213m • Resists claims based on ‘safe product’ defense Claims dismissed 221,000 • Provision determined using independent Claims outstanding 86,0

  53. Slide 53: Questions & Answers

    Questions & Answers Annual Results 19 September 2012 Bringing technology to life investor.relations@smiths.com Smiths Group plc Annualwww.smiths.com Results 2012 | 53

Smiths Group — FY2012 Earnings Presentation on 6ix